Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP76 is a processed pseudogene derived from the ribosomal protein L7a (RPL7A) gene. Pseudogenes like RPL7AP76 are DNA sequences similar to known genes but are non-coding and generally nonfunctional due to mutations or lack of regulatory elements necessary for expression. RPL7AP76 does not produce a functional protein product and is not known to have any biological activity or serve as a molecular target. The parent gene, RPL7A, is a structural component of the 60S ribosomal subunit, but RPL7AP76 itself has no known role in translation or in disease.[4]\n\nKey distinctions:\n- RPL7A is a protein-coding gene with diverse roles in ribosome function and some potential disease associations[1][3][5], but RPL7AP76 is a non-coding pseudogene.\n- Search results confirm that RPL7AP76 is not considered a therapeutic, diagnostic, or research target.\n\nIf you are seeking information about the protein-coding ribosomal protein, use \"ribosomal protein L7a\" (RPL7A) rather than RPL7AP76.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L7a pseudogene 76 (RPL7AP76).